Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Non-Current Assets (2023 - 2026)

Camp4 Therapeutics' Non-Current Assets history spans 3 years, with the latest figure at $3.7 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 68.86% to $3.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.7 million, a N/A change, with the full-year FY2025 number at $3.7 million, down 68.86% from a year prior.
  • Non-Current Assets hit $3.7 million in Q4 2025 for Camp4 Therapeutics, down from $8.7 million in the prior quarter.
  • Over the last five years, Non-Current Assets for CAMP hit a ceiling of $15.9 million in Q3 2024 and a floor of $3.7 million in Q4 2025.
  • Historically, Non-Current Assets has averaged $10.9 million across 3 years, with a median of $11.1 million in 2025.
  • Biggest five-year swings in Non-Current Assets: fell 20.15% in 2024 and later plummeted 68.86% in 2025.
  • Tracing CAMP's Non-Current Assets over 3 years: stood at $14.9 million in 2023, then fell by 20.15% to $11.9 million in 2024, then plummeted by 68.86% to $3.7 million in 2025.
  • Business Quant data shows Non-Current Assets for CAMP at $3.7 million in Q4 2025, $8.7 million in Q3 2025, and $10.2 million in Q2 2025.